Skip to main content
Deepak Nitrite Limited logo

Deepak Nitrite Limited — Investor Relations & Filings

Ticker · DEEPAKNTR ISIN · INE288B01029 LEI · 335800FKRXU8C9F4PI09 BSE.NS Manufacturing
Open in API
Filings indexed 1,548 across all filing types
Latest filing 2021-10-27 Regulatory Filings
Country IN India
Listing BSE.NS DEEPAKNTR

About Deepak Nitrite Limited

https://www.godeepak.com

Deepak Nitrite Limited is a multi-product chemical intermediary manufacturer. The company operates through four primary business segments: Basic Chemicals, Fine & Specialty Chemicals, Performance Products, and Phenolics. Its product portfolio includes sodium nitrite, sodium nitrate, nitro-toluenes, fuel additives, and optical brightening agents used in paper, detergent, and textile industries. Through its subsidiary, Deepak Phenolics Limited, it is a major producer of phenol, acetone, and isopropyl alcohol. The company serves diverse end-use industries such as agrochemicals, pharmaceuticals, rubber, colorants, and laminates. It maintains a strong focus on research and development and process innovation to ensure high-quality chemical intermediates and cost-efficient production.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding the loss of share certificates and the request for issuance of duplicate share certificates by a shareholder. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share transfer and related compliance. The content is about reporting a specific shareholder's lost share certificates and the administrative action taken by the Registrar and Transfer Agent. There are no financial statements, earnings data, management discussion, or other report content. The document is a regulatory compliance notification related to share certificate loss and transfer stop, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other specific categories like share issue, director dealings, or capital updates.
2021-10-27 English
Loss of Share Certificates
Regulatory Filings
2021-10-13 English
Information on loss of Shares Certificates
Regulatory Filings
2021-10-13 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding a Board Meeting scheduled to consider and approve the unaudited financial results for the quarter and half year ended 30th September 2021. It references Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of financial results. The document is short (1338 characters) and serves as a notification of an upcoming board meeting to approve interim financial results, not the financial report itself. Therefore, it is an announcement related to interim/quarterly financial results rather than the report containing the results. According to the classification rules, such a document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the meeting to approve interim results, not the interim report itself.
2021-10-12 English
DEEPAK NITRITE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2021 ,inter alia, to consider and approve Board Meeting for consideration ....
Regulatory Filings
2021-10-12 English
Updates
Regulatory Filings
2021-10-06 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.